These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1538560)

  • 1. Survival of zidovudine-treated patients with AIDS compared with that of contemporary untreated patients. Italian Zidovudine Evaluation Group.
    Vella S; Giuliano M; Pezzotti P; Agresti MG; Tomino C; Floridia M; Greco D; Moroni M; Visco G; Milazzo F
    JAMA; 1992 Mar; 267(9):1232-6. PubMed ID: 1538560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
    Chaisson RE; Keruly J; Richman DD; Moore RD
    Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study Group.
    Lundgren JD; Phillips AN; Pedersen C; Clumeck N; Gatell JM; Johnson AM; Ledergerber B; Vella S; Nielsen JO
    JAMA; 1994 Apr; 271(14):1088-92. PubMed ID: 8151850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sex, age and transmission category on the progression to AIDS and survival of zidovudine-treated symptomatic patients.
    Vella S; Giuliano M; Floridia M; Chiesi A; Tomino C; Seeber A; Barcherini S; Bucciardini R; Mariotti S
    AIDS; 1995 Jan; 9(1):51-6. PubMed ID: 7893441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zidovudine therapy, CD4+ and CD8+ counts are associated with a longer survival following AIDS onset.
    Fiala M; Swartz J; Teklehaimanot S; Kermani V; Funnye AS; Sayre JW; Gornbein JA
    Lymphology; 1997 Sep; 30(3):128-36. PubMed ID: 9313205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of patients receiving zidovudine before or after AIDS diagnosis: results of a German multicenter study. German AIDS Study Group.
    Clin Investig; 1994 Jan; 72(2):111-6. PubMed ID: 8186655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group.
    Spector SA; Gelber RD; McGrath N; Wara D; Barzilai A; Abrams E; Bryson YJ; Dankner WM; Livingston RA; Connor EM
    N Engl J Med; 1994 Nov; 331(18):1181-7. PubMed ID: 7935655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zidovudine and the natural history of the acquired immunodeficiency syndrome.
    Moore RD; Hidalgo J; Sugland BW; Chaisson RE
    N Engl J Med; 1991 May; 324(20):1412-6. PubMed ID: 2020297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential survival of patients with AIDS according to the 1987 and 1993 CDC case definitions.
    Vella S; Chiesi A; Volpi A; Giuliano M; Floridia M; Dally LG; Binkin N
    JAMA; 1994 Apr; 271(15):1197-9. PubMed ID: 7908705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of antiviral therapy with zidovudine: a retrospective study on HIV-positive hemophiliacs in Italy. Italian Group of Congenital Coagulopathies.
    Arcieri R; Puopolo M; Baudo F; Chiarotti F; De Rosa V; Schinaia N; Mori PG; Ghirardini A
    Haematologica; 1995; 80(1):25-30. PubMed ID: 7758987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health status and function with zidovudine or zalcitabine as initial therapy for AIDS. A randomized controlled trial. Roche 3300/ACTG 114 Study Group.
    Bozzette SA; Kanouse DE; Berry S; Duan N
    JAMA; 1995 Jan; 273(4):295-301. PubMed ID: 7815656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Race, sex, drug use, and progression of human immunodeficiency virus disease.
    Chaisson RE; Keruly JC; Moore RD
    N Engl J Med; 1995 Sep; 333(12):751-6. PubMed ID: 7643881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
    AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group.
    Volberding PA; Lagakos SW; Grimes JM; Stein DS; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS; Phair JP; Mitsuyasu RT
    JAMA; 1994 Aug; 272(6):437-42. PubMed ID: 7913730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of progression to AIDS in HIV-infected individuals: an update from the Italian Seroconversion Study.
    Rezza G
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 17 Suppl 1():S13-6. PubMed ID: 9586645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection.
    Selwyn PA; Alcabes P; Hartel D; Buono D; Schoenbaum EE; Klein RS; Davenny K; Friedland GH
    N Engl J Med; 1992 Dec; 327(24):1697-703. PubMed ID: 1359411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
    Volberding PA; Lagakos SW; Koch MA; Pettinelli C; Myers MW; Booth DK; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS
    N Engl J Med; 1990 Apr; 322(14):941-9. PubMed ID: 1969115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study Group.
    Moore RD; Keruly J; Richman DD; Creagh-Kirk T; Chaisson RE
    AIDS; 1992 Jul; 6(7):671-7. PubMed ID: 1503686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy.
    Pluda JM; Yarchoan R; Jaffe ES; Feuerstein IM; Solomon D; Steinberg SM; Wyvill KM; Raubitschek A; Katz D; Broder S
    Ann Intern Med; 1990 Aug; 113(4):276-82. PubMed ID: 1973886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of generalists' slow adoption of zidovudine in clinical practice.
    Markson LE; Cosler LE; Turner BJ
    Arch Intern Med; 1994 Jul; 154(13):1497-504. PubMed ID: 8018005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.